References
- Asai T, Tsuchiya Y, Okano K, et al (2012). Aflatoxin contamination of red chili pepper from Bolivia and Peru, countries with high gallbladder cancer incidence rates. Asian Pac J Cancer Prev, 13, 5167-70. https://doi.org/10.7314/APJCP.2012.13.10.5167
- Carriaga MT, Henson DE (1995). Liver, gallbladder, extrahepatic bile ducts and pancreas. Cancer, 75, 171-90. https://doi.org/10.1002/1097-0142(19950101)75:1+<171::AID-CNCR2820751306>3.0.CO;2-2
- Chhabra D, Oda K, Jagannath P, et al (2012). Chronic heavy metal exposure and gallbladder cancer risk in India, a comparative study with Japan. Asian Pac J Cancer Prev, 13, 187-90. https://doi.org/10.7314/APJCP.2012.13.1.187
- Fujii K, Yokozaki H, Yasui W, et al (1996). High frequency of p53 gene mutation in adenocarcinomas of the gallbladder. Cancer Epidemiol Biomarkers Prev, 5, 461-6.
- Funabiki T, Matsubara T, Miyakawa S, Ishihara S (2009). Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy. Langenbecks Arch Surg, 394, 159-69. https://doi.org/10.1007/s00423-008-0336-0
- Goldin RD, Roa JC (2009). Gallbladder cancer: a morphological and molecular update. Histopathology, 55, 218-29. https://doi.org/10.1111/j.1365-2559.2008.03192.x
- Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994). Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res, 54, 4855-78.
- Greene FL, Page DL, Fleming ID, et al (2002). American Joint Committee On Cancer Staging Manual, 6th edn (New York, Springer).
- Guo RS, Shi PD, Zhou J, Chen YY (2013). Somatostatin receptors 3, 4 and 5 play important roles in gallbladder cancer. Asian Pac J Cancer Prev, 14, 4071-5. https://doi.org/10.7314/APJCP.2013.14.7.4071
- Hanada K, Itoh M, Fujii K, et al (1996). K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct. Cancer, 77, 452-8. https://doi.org/10.1002/(SICI)1097-0142(19960201)77:3<452::AID-CNCR5>3.0.CO;2-M
- Hanada K, Tsuchida A, Iwao T, et al (1999). Gene mutations of K-ras in gallbladder mucosae and gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct. Am J Gastroenterol, 94, 1638-42. https://doi.org/10.1111/j.1572-0241.1999.01155.x
- Harris CC (1996). The 1995 Walter hubert lecture--molecular epidemiology of human cancer: insights from the mutational analysis of the p53 tumour-suppressor gene. Br J Cancer, 73, 261-9. https://doi.org/10.1038/bjc.1996.47
- Hussain SP, Harris CC (2000). Molecular epidemiology and carcinogenesis: endogenous and exogenous carcinogens. Mutat Res, 462, 311-22. https://doi.org/10.1016/S1383-5742(00)00015-6
- Iwase T, Nakazawa S, Yamao K, et al (1997). Ras gene point mutations in gallbladder lesions associated with anomalous connection of pancreatobiliary ducts. Hepatogastroenterology, 44, 1457-62.
- Jones PA, Buckley JD, Henderson BE, Ross RK, Pike MC (1991). From gene to carcinogen: a rapidly evolving field in molecular epidemiology. Cancer Res, 51, 3617-20.
- Lazcano-Ponce EC, Miquel JF, Munoz N, et al (2001). Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin, 51, 349-64. https://doi.org/10.3322/canjclin.51.6.349
- Matsubara T, Sakurai Y, Sasayama Y, et al (1996). K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction. Cancer, 77, 1752-7. https://doi.org/10.1002/(SICI)1097-0142(19960415)77:8+<1752::AID-CNCR27>3.3.CO;2-0
- Misra S, Chaturvedi A, Misra NC, Sharma ID (2003). Carcinoma of the gallbladder. Lancet Oncol, 4, 167-76. https://doi.org/10.1016/S1470-2045(03)01021-0
- Moore SP, Forman D, Pineros M, et al (2014). Cancer in indigenous people in Latin America and the Caribbean: a review. Cancer Med, 3, 70-80. https://doi.org/10.1002/cam4.134
- Moreno M, Pimentel F, Gazdar AF, Wistuba Ii, Miquel JF (2005). TP53 abnormalities are frequent and early events in the sequential pathogenesis of gallbladder carcinoma. Ann Hepatol, 4, 192-9.
- Nagahashi M, Ajioka Y, Lang I, et al (2008). Genetic changes of p53, K-ras, and microsatellite instability in gallbladder carcinoma in high-incidence areas of Japan and Hungary. World J Gastroenterol, 14, 70-5. https://doi.org/10.3748/wjg.14.70
- Ozturk M (1991). p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet, 338, 1356-9. https://doi.org/10.1016/0140-6736(91)92236-U
- Rai R, Tewari M, Kumar M, Singh AK, Shukla HS (2011). p53: its alteration and gallbladder cancer. Eur J Cancer Prev, 20, 77-85. https://doi.org/10.1097/CEJ.0b013e328341e371
- Randi G, Franceschi S, La Vecchia C (2006). Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer, 118, 1591-602. https://doi.org/10.1002/ijc.21683
- Rideout WM, 3rd, Coetzee GA, Olumi AF, Jones PA (1990). 5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. Science, 249, 1288-90. https://doi.org/10.1126/science.1697983
- Serra I, Yamamoto M, Calvo A, et al (2002). Association of chili pepper consumption, low socioeconomic status and longstanding gallstones with gallbladder cancer in a Chilean population. Int J Cancer, 102, 407-11. https://doi.org/10.1002/ijc.10716
- Srivastava V, Patel B, Kumar M, Shukla M, Pandey M (2013). Cyclin D1, retinoblastoma and p16 protein expression in carcinoma of the gallbladder. Asian Pac J Cancer Prev, 14, 2711-5. https://doi.org/10.7314/APJCP.2013.14.5.2711
- Takagi S, Naito E, Yamanouchi H, et al (1994). Mutation of the p53 gene in gallbladder cancer. Tohoku J Exp Med, 172, 283-9. https://doi.org/10.1620/tjem.172.283
- Taner CB, Nagorney DM, Donohue JH (2004). Surgical treatment of gallbladder cancer. J Gastrointest Surg, 8, 83-9. https://doi.org/10.1016/j.gassur.2003.09.022
- Tsuchiya Y, Terao M, Okano K, et al (2011). Mutagenicity and mutagens of the red chili pepper as gallbladder cancer risk factor in Chilean women. Asian Pac J Cancer Prev, 12, 471-6.
- Wistuba Ii, Gazdar AF (2004). Gallbladder cancer: lessons from a rare tumour. Nat Rev Cancer, 4, 695-706. https://doi.org/10.1038/nrc1429
- Wu Q, He XD, Yu L, Liu W, Tao LY (2012). The metabolic syndrome and risk factors for biliary tract cancer: a case-control study in China. Asian Pac J Cancer Prev, 13, 1963-9. https://doi.org/10.7314/APJCP.2012.13.5.1963
- Yokoyama N, Hitomi J, Watanabe H, et al (1998a). Mutations of p53 in gallbladder carcinomas in high-incidence areas of Japan and Chile. Cancer Epidemiol Biomarkers Prev, 7, 297-301.
- Yokoyama N, Watanabe H, Ajioka Y, et al (1998b). Genetic alterations in gallbladder carcinoma: a review. Nihon Geka Gakkai Zasshi, 99, 687-95.
Cited by
- High Frequency of Codon 12 but not Codon 13 and 61 K-ras Gene Mutations in Invasive Ductal Carcinoma of Breast in a South Indian Population vol.16, pp.8, 2015, https://doi.org/10.7314/APJCP.2015.16.8.3505
- CYP1A1, GSTM1, GSTT1 and TP53 Polymorphisms and Risk of Gallbladder Cancer in Bolivians vol.17, pp.2, 2016, https://doi.org/10.7314/APJCP.2016.17.2.781
- Gallbladder Carcinoma in the United States: A Population Based Clinical Outcomes Study Involving 22,343 Patients from the Surveillance, Epidemiology, and End Result Database (1973–2013) vol.2017, pp.1607-8462, 2017, https://doi.org/10.1155/2017/1532835